Following WHO alert: LANXESS counters Mpox threat with Rely+On Virkon

  • Effectiveness of Rely+On Virkon against Mpox pathogens scientifically proven
  • Disinfection is the key to preventing transmission

Cologne

In view of the increasing Mpox infections in Central and East Africa, the World Health Organization (WHO) has declared an international health emergency. 

The disinfectant Rely+On Virkon from specialty chemicals company LANXESS has been proven to be effective against the Mpox virus, formerly known as the “monkeypox virus”. This is confirmed by independent tests that confirm the product's effectiveness against the virus.

“Especially in times of rising infection rates, the choice of an effective disinfectant that has been proven to kill the target pathogen is crucial,” says Roy van Wel, Head of the market segment Hygiene and Care at LANXESS.

Rely+On Virkon is used for the disinfection of hard surfaces in hospitals, healthcare facilities, airports, public transportation terminals, clinics, shopping malls and many other public places.

Rely+On Virkon has proven to be effective against the pathogen and supports prevention in risk areas. It provides effective inactivation of the virus on hard surfaces, helping to contain the spread.

For more information on Rely+On Virkon, click here

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE
Modular plant for water purification usimg Lewatit TP 108 DW ion exchange resin. Operatot De Watergroep, Belgium

LANXESS’ ion exchange resin for mobile water treatment unit for PFAS removal

November 19, 2024
PRESS RELEASE
refrigeration lubricant, synthetic ester lubricant Everest ESR 220, HVAC (heating, ventilation and air conditioning) and refrigeration systems

LANXESS launches environmentally sustainable refrigeration lubricant Everest ESR 220

November 13, 2024
PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS significantly increases earnings in the third quarter of 2024

November 07, 2024
PRESS RELEASE
LANXESS Headquarters in Cologne

LANXESS signs contract to sell Urethane Systems business to UBE Corporation

October 03, 2024
PRESS RELEASE
LANXESS corporate headquarters in Cologne

LANXESS signs new sustainable credit line for EUR 800 million

September 26, 2024